New diagnostic possibilities with B·R·A·H·M·S Copeptin proAVP KRYPTOR
Learn moreMulticentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry
- Autoren: Giannitsis E, Clifford P, Slagman A, Ruedelstein R, Liebetrau C, Hamm C, Honnart D, Huber K, Vollert J, Simonelli C, Schröder M, Wiemer J, Mueller-Hennessen M, Schroer H, Kastner K, Möckel M
- Source: http://dx.doi.org/10.1136/bmjopen-2018-028311
- Indication: Cardiology
- Access: Open Access
- Product: Copeptin
Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome
- Autoren: Thomas Reinhold, Evangelos Giannitsis, Martin Moeckel, Lutz Frankenstein, Mehrshad Vafaie, Joern O. Vollert, Anna Slagman
- Source: https://doi.org/10.1371/journal.pone.0202133
- Indication: Cardiology
- Product: Copeptin
The combined copeptin/cTN testing has the potential to save costs and staff time in acute care and for the entire hospital stay. The primary explanations for these findings are early identification and ruling out patients without AMI along with the associated reduced need for acute medical treatment.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202133 >
Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome
- Autoren: Morawiec B, Kawecki D, Przywara-Chowaniec B, Opara M, Muzyk P, Ho L, Tat LC, Gabrysiak A, Muller O and Nowalany-Kozielska E
- Source: Dis Markers 2018;2018 6597387.
- Indication: Cardiology
- Access: Open Access
- Product: Copeptin
Copeptin appears to be an independent predictor of long-term mortality in a selected population of patients suspected for an ACS.
https://www.ncbi.nlm.nih.gov/pubmed/29619130 >